neuroConn GmbH
neuroConn GmbH develops CE-certified non-invasive brain stimulation and EEG/neurofeedback medical devices (THERA PRAX, NEURO PRAX, DC-STIMULATOR) sold to hospitals and clinics globally, operating within the neurocare group platform that combines device sales, owned TMS clinics, and BCIA-accredited clinician training.
- Company typePrivate
- Founded2005
- HeadquartersIlmenau, Germany
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What neuroConn GmbH does
neuroConn GmbH is a Germany-based medical device company founded in 2005 and headquartered in Ilmenau, specializing in non-invasive brain stimulation (NIBS) and neurophysiology equipment for clinical and research applications. Its core product portfolio — THERA PRAX transcranial stimulation systems, NEURO PRAX EEG/neurofeedback systems, and DC-STIMULATOR devices — is CE-certified and forms the hardware backbone of the broader neurocare group AG platform. The company's differentiating technology layer includes Neuro-Cardiac-Guided TMS (NCG-TMS), a proprietary intermittent Theta Burst Stimulation (iTBS) protocol, QEEG-based personalized targeting, and real-time closed-loop systems that combine brain stimulation with simultaneous EEG monitoring for adaptive therapy.
The business model is hybrid and vertically integrated. Revenue is generated through three primary channels: (1) B2B device sales of TMS, tDCS/tES, neurofeedback, and EEG/QEEG systems to hospitals, clinics, and research institutions; (2) operation of an owned and franchised clinic network spanning 11+ Netherlands locations, the USA, Australia, the UK, and Ireland; and (3) training and certification revenue through the neurocare Academy. Pricing for medical devices is quote-based and not publicly disclosed, consistent with enterprise medical equipment sales. Customer segments split between healthcare providers (psychiatrists, neurologists, psychologists) seeking evidence-based neuromodulation tools, patients with treatment-resistant mental health conditions, and academic research institutions running clinical trials.
Recent strategic activity reflects an aggressive expansion phase: EUR 16–19.3 million raised across multiple institutional rounds (TVM Capital Healthcare, Impact Expansion, bm|t, Apeiron/re.Mind), three FDA clearances in 2024 (iTBS protocol, OCD, adolescent depression), MDMA approval in Saudi Arabia (January 2026), and successive acquisitions of clinics (Smart TMS UK/Ireland, MeJa Psychologie, Brain Dynamics) and device makers (MAG & More). Geographic expansion has reached Japan via a Kyowa joint venture and MENA via a dedicated regional subsidiary. Investors include re.Mind, explicitly tied to public listing preparation, suggesting the group is positioning for a near-term capital markets event.
neuroConn GmbH firmographics
Firmographics- Name
- neuroConn GmbH
- Legal name
- neuroConn GmbH
- Website
- https://neurocaregroup.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- neuroConn GmbH develops CE-certified non-invasive brain stimulation and EEG/neurofeedback medical devices (THERA PRAX, NEURO PRAX, DC-STIMULATOR) sold to hospitals and clinics globally, operating within the neurocare group platform that combines device sales, owned TMS clinics, and BCIA-accredited clinician training.
- Ownership category
- akta.pro rank
neuroConn GmbH industry classification
Industry- Product category
- Neuroscience Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS) (HLAHAEAK)
- akta.pro secondary industry
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
Keywords
Where neuroConn GmbH is headquartered
LocationHeadquarters
- HQ city
- Ilmenau
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
neuroConn GmbH business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Distribution channels5 records
Marketing channels6 records
neuroConn GmbH product offering
Product offeringCore offering
neuroConn GmbH develops and manufactures certified neuroscience medical devices for non-invasive brain stimulation, including the THERA PRAX transcranial stimulation system, NEURO PRAX EEG recording and neurofeedback system, and DC-STIMULATOR devices. The company specializes in closed-loop neuromodulation solutions that integrate brain stimulation with simultaneous real-time EEG monitoring and QEEG-based targeting for clinical and research applications.
Product overview
neuroConn GmbH, operating as part of the neurocare group ecosystem, develops neurostimulation and neurophysiology devices. The core product portfolio includes the THERA PRAX® transcranial stimulation system and NEURO PRAX® EEG recording system, both certified under EU standards. The company specializes in closed-loop neuromodulation solutions that combine brain stimulation with real-time neural monitoring, including Target Engagement technologies for measuring treatment precision. neuroConn products are designed for both clinical practice and research applications in the field of non-invasive brain stimulation (NIBS).
Differentiator
Problem solved
Functional benefit
Brands
- THERA PRAX: Neurostimulation device system
- NEURO PRAX
Products and services
- THERA PRAX transcranial stimulation system Certified medical device for transcranial magnetic and electrical stimulation, designed for clinical therapy and neuroscience research use by psychiatrists, neurologists, and research institutions.
- NEURO PRAX EEG and neurofeedback system EEG recording and neurofeedback system designed for clinical neurophysiology applications, with compatibility for integrated neuromodulation modalities.
- DC-STIMULATOR transcranial electrical stimulation device Certified transcranial direct current and electrical stimulation (tDCS/tES) device for clinical and research use.
- Closed-Loop Solutions Real-time feedback systems combining brain stimulation with simultaneous EEG monitoring to enable adaptive treatment protocols based on neural activity, for clinical and research applications.
- Target Engagement Technologies Technologies and methodologies for measuring and verifying brain stimulation target engagement during neuromodulation treatments, improving precision and validation of stimulation effects.
Companies that use neuroConn GmbH
Customer profileSegments3 records
Ideal customer profiles2 records
neuroConn GmbH technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
neuroConn GmbH partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered regional and core.
- Smart TMS Clinics (UK & Ireland)regionalAcquired Smart TMS Clinics in UK and Ireland; clinics have been rebranded under neurocare identity, adding significant coverage in British Isles.
- STIMIT AGcoreStrategic cooperation with Stimit AG, a company developing solutions for functional muscle stimulation integrated with neuromodulation therapies.
- Fondazione Policlinico Gemelli (Italy)coreStrategic cooperation in Rome to deliver neuromodulation treatments through one of Italy's leading academic medical centers.
- MAG & More (Germany)coreGerman-based leader of Transcranial Magnetic Stimulation devices joins neurocare group. MAG & More is now part of the neurocare group family.
- Kyowa (Japan)regionalEquity participation and strategic joint venture in Japan for market entry and distribution.
- NRx PharmaceuticalscoreJoint offering of neuroplastic therapy integrating TMS, medications, and psychotherapy targeting depression, PTSD, and other mental health afflictions. NASDAQ:NRXP.
- Mid-Ohio Behavioral HealthregionalCollaborative arrangement to expand neurocare's US footprint through partnership with Mid-Ohio Behavioral Health.
- MeJa Psychologie (Netherlands)regionalAcquisition of perinatal mental health specialists expanding neurocare clinic network to 11 locations in Netherlands.
- Brainclinics Research InstitutecoreResearch partnership for TMS and OCD treatment studies; validated NCG-TMS proof-of-concept; published in International Journal of Clinical and Health Psychology.
Recent moves8 records
Expansion highlights7 records
neuroConn GmbH competitors and assessment
Company assessmentDirect peers
- Soterix Medical: US-based developer of tDCS, tACS, and HD-tES neuromodulation systems for research and clinical applications. Directly comparable as a non-invasive brain stimulation device manufacturer with overlapping product portfolio to neuroConn's DC-STIMULATOR line.
- Neuronetics: US-based public company (NASDAQ:STIM) and the dominant installed-base player in TMS systems for depression via the NeuroStar platform. Directly comparable as a TMS device manufacturer targeting the same psychiatrist/mental health clinician customer base.
- Brainsway: Israel-based medical device company commercializing Deep TMS (dTMS) systems for depression, OCD, and smoking addiction. Competes head-to-head with neuroConn in TMS device sales and FDA-cleared indications.
- Magstim: UK-based manufacturer of TMS stimulators and coils used widely in clinical and research settings. Directly comparable as a TMS device maker serving neurology and psychiatry researchers and clinicians.
- Compumedics: Australia-based manufacturer of EEG and sleep diagnostic equipment. Comparable through overlapping EEG/QEEG product categories with neuroConn's NEURO PRAX system.
- MagVenture: Danish manufacturer of TMS systems (MagPro) used in both research and clinical depression treatment. Direct competitor in the TMS device market with similar FDA-cleared depression indication.
- Neurosoft: Russia-headquartered manufacturer of EEG, EMG, and neurostimulation equipment for clinical and research use. Directly comparable through overlap in EEG and tDCS/tES product categories.
- eemagine: Berlin-based developer of high-density EEG systems for research and clinical applications. Comparable as a German-headquartered neuroscience device company targeting overlapping research customers.
- Rogue Research (Brainsight): Canadian manufacturer of TMS neuronavigation systems (Brainsight). Comparable as a complementary TMS technology provider used by the same clinician and research customers that buy neuroConn's neuronavigation products.
Broad incumbents
- Brainlab: Large German-headquartered medtech company offering neuronavigation, surgical planning, and radiation oncology systems. Comparable through overlap with neuroConn's TMS neuronavigation offerings, but operates across a much broader clinical portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
neuroConn GmbH social profiles
Digital presenceneuroConn GmbH compliance and trust
Trust signalCompliance4 records
neuroConn GmbH financial estimates
Financial estimateRevenue estimate
Valuation estimate
neuroConn GmbH leadership team
Management profileNumber of profiles
Profiles14 records
neuroConn GmbH funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
neuroConn GmbH M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about neuroConn GmbH
What does neuroConn GmbH do?
neuroConn GmbH develops and manufactures certified neuroscience medical devices for non-invasive brain stimulation, including the THERA PRAX transcranial stimulation system, NEURO PRAX EEG recording and neurofeedback system, and DC-STIMULATOR devices. The company specializes in closed-loop neuromodulation solutions that integrate brain stimulation with simultaneous real-time EEG monitoring and QEEG-based targeting for clinical and research applications.
When was neuroConn GmbH founded?
neuroConn GmbH was founded in 2005. It employs 1 to 10 people.
Where is neuroConn GmbH based?
neuroConn GmbH is headquartered in Ilmenau, Germany, in the Europe region.
Who are neuroConn GmbH's main competitors?
Direct peers on record are Soterix Medical, Neuronetics, Brainsway, Magstim, Compumedics, MagVenture, Neurosoft, eemagine and Rogue Research (Brainsight). Brainlab is listed as a broad incumbent.
Does neuroConn GmbH have an API?
No public API is recorded for neuroConn GmbH.
What industry is neuroConn GmbH in?
neuroConn GmbH's product category is Neuroscience Medical Devices. Its primary akta.pro industry code is HLAHAEAK, Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS), with a secondary code of HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables). Its NAICS code is 334510 and its SIC code is 3845.